[Congressional Record Volume 169, Number 195 (Tuesday, November 28, 2023)]
[House]
[Page H5933]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                  DEFENSE PRODUCTION ACT AND MEDICINE

  (Ms. KAPTUR asked and was given permission to address the House for 1 
minute and to revise and extend her remarks.)
  Ms. KAPTUR. Madam Speaker, what America makes and grows, makes and 
grows America and grows our middle class. Thus, let me applaud the 
Biden administration's decision to utilize the Defense Production Act 
to reshore the domestic manufacturing of essential medicines critical 
for our national security.
  This move is a strategic response to the challenges America faces, 
particularly keeping inflation in check and healing the vulnerabilities 
in our pharmaceutical supply chain.
  The book, ``China Rx,'' highlights the growing number of our 
country's reliance on foreign-made medicines, particularly from China. 
They pose a significant national security risk to both our military and 
civilian sectors.
  The Defense Production Act offers a vital tool to onshore and 
increased domestic production of essential medicines. In a world where 
the availability of essential medicines can be a matter of life and 
death, our Nation must take strong measures to resecure our domestic 
pharmaceutical supply chain.
  The Defense Production Act is a significant step toward achieving 
this goal. What America makes and grows, makes and grows a stronger and 
more secure America.

                          ____________________